Cargando…

Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study

PURPOSE: To develop and validate a risk prediction model for coronary heart disease (CHD) in snorers with hypertension, including traditional and new risk factors. PATIENTS AND METHODS: Twenty factors were evaluated in the records of 2810 snorers with hypertension. Training (70%) and validation (30%...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengru, Wang, Menghui, Zhu, Qing, Yao, Xiaoguang, Heizhati, Mulalibieke, Cai, Xintian, Ma, Yue, Wang, Run, Hong, Jing, Yao, Ling, Sun, Le, Yue, Na, Ren, Yingli, Li, Nanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624218/
https://www.ncbi.nlm.nih.gov/pubmed/36329827
http://dx.doi.org/10.2147/RMHP.S374339
_version_ 1784822185146187776
author Wang, Mengru
Wang, Menghui
Zhu, Qing
Yao, Xiaoguang
Heizhati, Mulalibieke
Cai, Xintian
Ma, Yue
Wang, Run
Hong, Jing
Yao, Ling
Sun, Le
Yue, Na
Ren, Yingli
Li, Nanfang
author_facet Wang, Mengru
Wang, Menghui
Zhu, Qing
Yao, Xiaoguang
Heizhati, Mulalibieke
Cai, Xintian
Ma, Yue
Wang, Run
Hong, Jing
Yao, Ling
Sun, Le
Yue, Na
Ren, Yingli
Li, Nanfang
author_sort Wang, Mengru
collection PubMed
description PURPOSE: To develop and validate a risk prediction model for coronary heart disease (CHD) in snorers with hypertension, including traditional and new risk factors. PATIENTS AND METHODS: Twenty factors were evaluated in the records of 2810 snorers with hypertension. Training (70%) and validation (30%) sets were created by random allocation of data, and a new nomogram model was developed. The model’s discrimination and calibration were measured by calculating the area under the receiver operating curve (AUC) and creating calibration charts. The performance of the nomogram model was compared with that of the Prediction for ASCVD Risk in China (China-PAR) and Framingham models by decision curve analysis. An optimal cutoff point for the risk score in the training set was computed to stratify patients. RESULTS: In the nomogram model, the AUCs for predicting CHD at 5, 7 and 9 years in the training set were 0.706 (95% confidence interval [CI] 0.649–0.763), 0.703 (95% CI 0.655–0.751) and 0.669 (95% CI 0.593–0.744), respectively. The respective AUCs were 0.682 (95% CI 0.607–0.758), 0.689 (95% CI 0.618–0.760) and 0.664 (95% CI 0.539–0.789) in the validation set. The calibration chart showed that the predicted events from the nomogram score were close to the observed events. Decision curve analysis indicated that the nomogram score was slightly better than the Prediction for ASCVD Risk in China (China-PAR) and Framingham models for predicting the risk of CHD in snorers with hypertension. A cutoff point was identified for being CHD-free (a nomogram score of ≤121), which could be helpful for the early identification of individuals at high-risk of CHD. CONCLUSION: The nomogram score predicts the risk probability of CHD in snorers with hypertension at 5, 7 and 9 years, and shows good capability in terms of discrimination and calibration. It may be a useful tool for identifying individuals at high risk of CHD.
format Online
Article
Text
id pubmed-9624218
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96242182022-11-02 Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study Wang, Mengru Wang, Menghui Zhu, Qing Yao, Xiaoguang Heizhati, Mulalibieke Cai, Xintian Ma, Yue Wang, Run Hong, Jing Yao, Ling Sun, Le Yue, Na Ren, Yingli Li, Nanfang Risk Manag Healthc Policy Original Research PURPOSE: To develop and validate a risk prediction model for coronary heart disease (CHD) in snorers with hypertension, including traditional and new risk factors. PATIENTS AND METHODS: Twenty factors were evaluated in the records of 2810 snorers with hypertension. Training (70%) and validation (30%) sets were created by random allocation of data, and a new nomogram model was developed. The model’s discrimination and calibration were measured by calculating the area under the receiver operating curve (AUC) and creating calibration charts. The performance of the nomogram model was compared with that of the Prediction for ASCVD Risk in China (China-PAR) and Framingham models by decision curve analysis. An optimal cutoff point for the risk score in the training set was computed to stratify patients. RESULTS: In the nomogram model, the AUCs for predicting CHD at 5, 7 and 9 years in the training set were 0.706 (95% confidence interval [CI] 0.649–0.763), 0.703 (95% CI 0.655–0.751) and 0.669 (95% CI 0.593–0.744), respectively. The respective AUCs were 0.682 (95% CI 0.607–0.758), 0.689 (95% CI 0.618–0.760) and 0.664 (95% CI 0.539–0.789) in the validation set. The calibration chart showed that the predicted events from the nomogram score were close to the observed events. Decision curve analysis indicated that the nomogram score was slightly better than the Prediction for ASCVD Risk in China (China-PAR) and Framingham models for predicting the risk of CHD in snorers with hypertension. A cutoff point was identified for being CHD-free (a nomogram score of ≤121), which could be helpful for the early identification of individuals at high-risk of CHD. CONCLUSION: The nomogram score predicts the risk probability of CHD in snorers with hypertension at 5, 7 and 9 years, and shows good capability in terms of discrimination and calibration. It may be a useful tool for identifying individuals at high risk of CHD. Dove 2022-10-28 /pmc/articles/PMC9624218/ /pubmed/36329827 http://dx.doi.org/10.2147/RMHP.S374339 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Mengru
Wang, Menghui
Zhu, Qing
Yao, Xiaoguang
Heizhati, Mulalibieke
Cai, Xintian
Ma, Yue
Wang, Run
Hong, Jing
Yao, Ling
Sun, Le
Yue, Na
Ren, Yingli
Li, Nanfang
Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title_full Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title_fullStr Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title_full_unstemmed Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title_short Development and Validation of a Coronary Heart Disease Risk Prediction Model in Snorers with Hypertension: A Retrospective Observed Study
title_sort development and validation of a coronary heart disease risk prediction model in snorers with hypertension: a retrospective observed study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624218/
https://www.ncbi.nlm.nih.gov/pubmed/36329827
http://dx.doi.org/10.2147/RMHP.S374339
work_keys_str_mv AT wangmengru developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT wangmenghui developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT zhuqing developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT yaoxiaoguang developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT heizhatimulalibieke developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT caixintian developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT mayue developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT wangrun developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT hongjing developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT yaoling developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT sunle developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT yuena developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT renyingli developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy
AT linanfang developmentandvalidationofacoronaryheartdiseaseriskpredictionmodelinsnorerswithhypertensionaretrospectiveobservedstudy